Therapeutic Targeting of B Cells for Rheumatic Autoimmune Diseases. This article reviews the current knowledge of B-cell biology and pathogenesis as well as the modern therapeutic approaches for rheumatic autoimmune diseases focusing in particular on the targeting of B-cell-specific surface molecules and on the blocking of B-cell activation and survival. Engel P, Pharmacol Rev. 2011 Jan 18. (Also see: Causes of Scleroderma - B cells)
This item was posted in the ISN Newsroom. Please check the newsroom daily for updates on scleroderma and other related articles.
ISN Assistant News Guide
International Scleroderma Network(ISN)
Therapeutic Targeting of B Cells for Rheumatic Autoimmune Diseases.
No replies to this topic